Home > Drug Search >
  • company_query: Apoxis
  •   > 
Drug Filter
Category:
chemistry (7) biology (21)
Status:
Approved (10) Phase Ⅲ (5) Phase Ⅱ (10) Phase Ⅰ (3)
Clinical Stage:
Active (13) Discontinued (5)
Bio-Type:
Gene therapy (1) Vaccine (6) Microbial extract (1) Recombinant cytokines (5) Recombinant hormone (1) Whole antibody (3)
Indication:
Allergic rhinitis (AR) (1) Anemia (3) Asthma (2) Bladder cancer (1) Breast cancer (2) Chronic obstructive pulmonary disease (COPD) (1) Giardia lamblia disease (1) Coronary artery disease (CAD) (1) Vaginal trichomoniasis (1) Amoebiasis (1) Trichomoniasis (1) Herpes simplex virus (1) HBV infection (2) HCV infection (2) HIV infection (1) Blepharospasm (1) Glabellar line (1) Equinus foot deformity (1) Lymphoma (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) HEV infection (1) Prostate cancer (2) Rheumatoid arthritis (RA) (1) Thrombocytopenia (1) Type 2 diabetes (1) Japanese encephalitis (1) Colorectal cancer (2) Dermatitis (1) Stroke (1) Cervical carcinoma (1) Type 1 diabetes (1) Neutropenia (1) Condylomata acuminata (2) Bacterial Vaginosis (BV) (1) Muscle spasticity (1) Acute kidney injury (1) hematological malignancies (1) Human papillomavirus infections (HPV) (1) Spasticity (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top